1. Cell Biology
Download icon

LAP2alpha maintains a mobile and low assembly state of A-type lamins in the nuclear interior

  1. Nana Naetar  Is a corresponding author
  2. Konstantina Georgiou
  3. Christian Knapp
  4. Irena Bronshtein
  5. Elisabeth Zier
  6. Petra Fichtinger
  7. Thomas Dechat
  8. Yuval Garini
  9. Roland Foisner  Is a corresponding author
  1. Medical University Vienna, Austria
  2. Bar Ilan University, Israel
Research Article
  • Cited 1
  • Views 795
  • Annotations
Cite this article as: eLife 2021;10:e63476 doi: 10.7554/eLife.63476

Abstract

Lamins form stable filaments at the nuclear periphery in metazoans. Unlike B-type lamins, lamins A and C localize also in the nuclear interior, where they interact with lamin-associated polypeptide 2 alpha (LAP2a). Using antibody labeling, we previously observed a depletion of nucleoplasmic A-type lamins in mouse cells lacking LAP2a. Here we show that loss of LAP2a actually causes formation of larger, biochemically stable lamin A/C structures in the nuclear interior that are inaccessible to lamin A/C antibodies. While nucleoplasmic lamin A forms from newly expressed pre-lamin A during processing and from soluble mitotic lamins in a LAP2a-independent manner, binding of LAP2a to lamins A/C during interphase inhibits formation of higher order structures, keeping nucleoplasmic lamin A/C in a mobile state independent of lamin A/C S22 phosphorylation. We propose that LAP2a is essential to maintain a mobile lamin A/C pool in the nuclear interior, which is required for proper nuclear functions.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2G-H, Figure 4A-B and Figure 6A

Article and author information

Author details

  1. Nana Naetar

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    For correspondence
    nana.naetar@univie.ac.at
    Competing interests
    The authors declare that no competing interests exist.
  2. Konstantina Georgiou

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Christian Knapp

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2463-5775
  4. Irena Bronshtein

    Physics Department and Nanotechnology Institute, Bar Ilan University, Ramt Gan, Israel
    Competing interests
    The authors declare that no competing interests exist.
  5. Elisabeth Zier

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  6. Petra Fichtinger

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  7. Thomas Dechat

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  8. Yuval Garini

    The Mina & Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
    Competing interests
    The authors declare that no competing interests exist.
  9. Roland Foisner

    Max Perutz Labs, Medical University Vienna, Vienna, Austria
    For correspondence
    roland.foisner@meduniwien.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4734-4647

Funding

Austrian Science Fund (P26492-B20,P29713-B28,P32512-B)

  • Roland Foisner

Austrian Academy of Sciences (APART 11657)

  • Nana Naetar

Israel Science Foundation (ISF grant 1219/17)

  • Irena Bronshtein
  • Yuval Garini

European Cooperation in Science and Technology (COST-STSM-BM1002-8698,COST-STSM-BM1002-11436)

  • Thomas Dechat

European Molecular Biology Organization (ASTF 316-2011)

  • Thomas Dechat

S Grosskopf Grant

  • Irena Bronshtein
  • Yuval Garini

Austrian Academy of Sciences (ÖAW DOC 25725)

  • Konstantina Georgiou

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Megan C King, Yale School of Medicine, United States

Publication history

  1. Received: September 28, 2020
  2. Accepted: February 18, 2021
  3. Accepted Manuscript published: February 19, 2021 (version 1)
  4. Version of Record published: March 8, 2021 (version 2)

Copyright

© 2021, Naetar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 795
    Page views
  • 132
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    Lisa M Strong et al.
    Research Article Updated

    Autophagy is a cellular process that degrades cytoplasmic cargo by engulfing it in a double-membrane vesicle, known as the autophagosome, and delivering it to the lysosome. The ATG12–5–16L1 complex is responsible for conjugating members of the ubiquitin-like ATG8 protein family to phosphatidylethanolamine in the growing autophagosomal membrane, known as the phagophore. ATG12–5–16L1 is recruited to the phagophore by a subset of the phosphatidylinositol 3-phosphate-binding seven-bladedß -propeller WIPI proteins. We determined the crystal structure of WIPI2d in complex with the WIPI2 interacting region (W2IR) of ATG16L1 comprising residues 207–230 at 1.85 Å resolution. The structure shows that the ATG16L1 W2IR adopts an alpha helical conformation and binds in an electropositive and hydrophobic groove between WIPI2 ß-propeller blades 2 and 3. Mutation of residues at the interface reduces or blocks the recruitment of ATG12–5–16 L1 and the conjugation of the ATG8 protein LC3B to synthetic membranes. Interface mutants show a decrease in starvation-induced autophagy. Comparisons across the four human WIPIs suggest that WIPI1 and 2 belong to a W2IR-binding subclass responsible for localizing ATG12–5–16 L1 and driving ATG8 lipidation, whilst WIPI3 and 4 belong to a second W34IR-binding subclass responsible for localizing ATG2, and so directing lipid supply to the nascent phagophore. The structure provides a framework for understanding the regulatory node connecting two central events in autophagy initiation, the action of the autophagic PI 3-kinase complex on the one hand and ATG8 lipidation on the other.

    1. Cell Biology
    Laura Le Pelletier et al.
    Research Article

    Aging is associated with central fat redistribution and insulin resistance. To identify age-related adipose features, we evaluated the senescence and adipogenic potential of adipose-derived-stromal cells (ASCs) from abdominal subcutaneous fat obtained from healthy normal-weight young (<25y) or older women (>60y). Increased cell passages of young-donor ASCs (in vitro aging), resulted in senescence but not oxidative stress. ASC-derived adipocytes presented impaired adipogenesis but no early mitochondrial dysfunction. Conversely, aged-donor ASCs at early passages displayed oxidative stress and mild senescence. ASC-derived adipocytes exhibited oxidative stress, and early mitochondrial dysfunction but adipogenesis was preserved. In vitro aging of aged-donor ASCs resulted in further increased senescence, mitochondrial dysfunction, oxidative stress and severe adipocyte dysfunction. When in vitro aged young-donor ASCs were treated with metformin, no alteration was alleviated. Conversely, metformin treatment of aged-donor ASCs decreased oxidative stress and mitochondrial dysfunction resulting in decreased senescence. Metformin's prevention of oxidative stress and of the resulting senescence improved the cells' adipogenic capacity and insulin sensitivity. This effect was mediated by the activation of AMP-activated-protein-kinase as revealed by its specific inhibition and activation. Overall, aging ASC-derived adipocytes presented impaired adipogenesis and insulin sensitivity. Targeting stress-induced senescence of ASCs with metformin may improve age-related adipose tissue dysfunction.